医护一体化模式在胸腰椎骨折患者护理中的应用

Application of Integrated Medical Care Mode in the Nursing of Patients with Thoracolumbar Fracture

目的探讨医护一体化模式在胸腰椎骨折患者护理中的应用效果。方法将46例胸腰椎骨折患者随机分为对照组(n=23)和观察组(n=23)。对照组采用常规护理,观察组在对照组基础上采用医护一体化模式,两组均连续护理14 d。对比两组患者的相关手术指标、护理前后VAS评分及并发症发生率。结果观察组的术中出血量少于对照组,手术时间、住院时间短于对照组(P均<0.05)。护理前,两组的VAS评分比较差异无统计学意义(P>0.05);护理后,两组的VAS评分低于护理前,且观察组的VAS评分低于对照组(P均<0.05)。观察组的并发症发生率为8.70%,明显低于对照组的34.78%(P <0.05)。结论医护一体化模式在胸腰椎骨折患者护理中的应用效果显著,可有效减轻患者的疼痛情况,减少术中出血量,缩短手术时间和住院时间,降低并发症发生率,值得临床推广应用。

Objective To explore the application effect of integrated medical care mode in the nursing of patients with thoracolumbar fracture. Methods 46 patients with thoracolumbar fracture were randomly divided into control group(n = 23) and observation group(n =23). The control group received routine nursing, and the observation group received integrated medical care mode on the basis of the control group. Both groups were given continuous nursing for 14 days. The related operation indicators, VAS scores before and after nursing and incidence of complications were compared between the two groups. Results The intraoperative blood loss of the observation group was less than that of the control group, and the operation time and hospitalization time were shorter than those of the control group(all P <0.05).Before nursing, no statistical difference was found in the VAS score between the two groups(P >0.05). After nursing, the VAS scores of the two groups were lower than those before nursing, and the VAS score of the observation group was lower than that of the control group(all P<0.05). The incidence of complications in the observation group was 8.70%, significantly lower than 34.78% in the control group(P <0.05).Conclusions Integrated medical care mode in the nursing of patients with thoracolumbar fracture has significant application effect, and can effectively relieve the pain of patients, reduce the intraoperative blood loss, shorten the operation time and hospitalization time, and reduce the incidence of complications, which is worthy of clinical promotion and application.